US Patent 10392421 Cytotoxic peptides and conjugates thereof
Patent 10392421 was granted and assigned to Novartis on August, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+96 characters)
Article
Patent abstract
Disclosed herein are novel cytotoxic peptides of formula (I) as described herein:
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Bernhard Hubert Geierstanger0
Jan Grunewald0
Tetsuo Uno0
Weijia Ou0
Xing Wang0
Yongqin Wan0
Yunho Jin0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103924210
Date of Patent
August 27, 2019
0Patent Application Number
159615310
Date Filed
April 24, 2018
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 8 Mar, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10392421 Cytotoxic peptides and conjugates thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10392421
Date of patent
August 27, 2019
Patent application number
15961531
Date Filed
April 24, 2018
Patent primary examiner
Find more entities like US Patent 10392421 Cytotoxic peptides and conjugates thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
